Results 51 to 60 of about 6,828 (196)

A review on technology and different probes in transscleral cyclophotocoagulation

TNOA Journal of Ophthalmic Science and Research, 2022
Glaucoma is a chronic progressive optic neuropathy, characterised by retinal ganglion cell loss leading to optic nerve head changes and visual field defects.
M Salu, Murali Ariga, Pratheeba D Nivean, M Nivean   +3 more
doaj   +1 more source

Long‐term limitations and complications of trans‐scleral diode laser cycloablation for refractory glaucoma

Clinical &Experimental Ophthalmology, Volume 51, Issue 2, Page 131-136, March 2023., 2023
Abstract Background Trans‐scleral diode laser cycloablation (cyclodiode) is effective in the short‐term management of refractory glaucoma where alternative treatments are not feasible. Long‐term outcomes of 5‐years or more are not well‐documented, particularly in relation to intraocular pressure (IOP) control, need for further procedures and ...
Tabitha M. Scott, Eugene R. Ting, Stephen J. Vincent, Graham A. Lee   +3 more
wiley   +1 more source

XEN45 Gel Stent Combined with Healaflow Injectable Viscoelastic Implant

Case Reports in Ophthalmological Medicine, Volume 2023, Issue 1, 2023., 2023
Purpose. To introduce a potential solution for failed glaucoma surgeries by proposing an optional surgical procedure in conjunction with the use of Healaflow (Anteis S.A., Geneva, Switzerland) as a spacer, which may potentially reduce the failure rate. Case Presentation.
Eloy Villarreal, Eran Berkowitz, Beatrice Tiosano, Cristiano Giusti   +3 more
wiley   +1 more source

Micropulse transscleral cyclophotocoagulation Cyclo G6 laser at low energy levels: Initial results in Indian eyes with advanced glaucoma treated in a single session

Indian Journal of Ophthalmology. Case Reports, 2021
Micropulse–transscleral–cyclophotocoagulation [MPTSCPC] delivered with the G6 laser system is one of the newer laser systems which purports greater safety without compromising efficiency in the reduction of intraocular pressure. This is due to the pulsed
Vanita Pathak-Ray
doaj   +1 more source

Long-Term Postoperative Outcomes of Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) in Patients with Glaucoma [PDF]

Clinical Ophthalmology
Shoichiro Kusuda, Eiki Oshida, Mana Gonmori, Tomoharu Nishimura, Shigeki MachidaDepartment of Ophthalmology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Saitama, JapanCorrespondence: Eiki Oshida, Department of Ophthalmology, Dokkyo ...
Kusuda S, Oshida E, Gonmori M, Nishimura T, Machida S   +4 more
doaj   +1 more source

Outcomes of Anterior Chamber, Sulcus, and Pars Plana Glaucoma Drainage Device Placement in Glaucoma Patients

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Purpose. To assess outcomes of anterior chamber (AC), sulcus, and pars plana (PP) glaucoma drainage device (GDD) placement in glaucoma patients. Patients and Methods. Retrospective evaluation of glaucoma patients who underwent GDD insertion in the AC, sulcus, or PP at Massachusetts Eye and Ear between November 2016 and May 2021.
Sandy Samuel, Enchi K. Chang, Sanchay Gupta, Marika Chachanidze, Cameron E. Neeson, John B. Miller, Ta Chen Chang, David A. Solá-Del Valle, Alessandro Meduri   +8 more
wiley   +1 more source

Topical Anesthesia Offers Sufficient Pain Control for MicroPulse Transscleral Laser Therapy for Glaucoma

Journal of Ophthalmology, Volume 2022, Issue 1, 2022., 2022
Introduction. The aim of this study was to evaluate patient pain during and after MicroPulse Transscleral Laser Therapy (TLT) and vision‐related quality of life using two different anesthesia protocols: “Topical Plus” anesthesia without standby anesthesia (study group), and analgosedation with standby anesthesia (control group). Methods.
Belgin Vasella, Marc Töteberg-Harms, Jean-Claude Mwanza   +2 more
wiley   +1 more source

XEN® Gel Stent compared to PRESERFLO™ MicroShunt implantation for primary open‐angle glaucoma: two‐year results

Acta Ophthalmologica, Volume 99, Issue 3, Page e433-e440, May 2021., 2021
Abstract Purpose To evaluate the long‐term efficacy and safety of two minimally invasive glaucoma surgery implants with a subconjunctival drainage approach: the XEN45 Gel Stent® (Xen) implant and the PRESERFLO™ MicroShunt (MicroShunt). Methods Retrospective comparative case series of primary open‐angle glaucoma (POAG) patients with at least 6 months of
Lotte M.J. Scheres, Stefani Kujovic‐Aleksov, Wishal D. Ramdas, Ronald M.P.C. de Crom, Lianne C.G. Roelofs, Tos T.J.M. Berendschot, Carroll A.B. Webers, Henny J.M. Beckers   +7 more
wiley   +1 more source

What Is New in Glaucoma: From Treatment to Biological Perspectives

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Glaucoma is a chronic silent disease and an irreversible cause of blindness worldwide. Research has made many efforts to improve disease control and especially to anticipate both early diagnosis and treatment of advanced stages of glaucoma. In terms of prevention, networking between professionals and nonprofessionals is an important goal to disseminate
Raffaele Nuzzi, Paola Marolo, Alessia Nuzzi, Steffen Heegaard   +3 more
wiley   +1 more source

Surgical and Perioperative Considerations for the Treatment of Cataract in Eyes with Glaucoma: A Literature Review

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Cataract surgery in the presence of glaucoma poses certain challenges that need to be addressed to offer the maximum benefit without complications. In this paper, we are reviewing the preoperative assessment, surgical options, the planning, and postoperative care.
Kleonikos Tsakiris, George Kontadakis, Panagiotis Georgoudis, Zisis Gatzioufas, Athanasios Vergados, Dirk Sandner   +5 more
wiley   +1 more source